Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
TOP-subsidie voor onderzoek naar vroege hersenafwijkingen Alzheimer
feb 2019 | Dementie